Artificial intelligence has taken the medical device industry by storm - even adding a layer of complexity to the operating room that's resulting in patients being hurt, some health professionals claim. As Reuters reports, the TruDi Navigation System by device maker Acclarent was designed to treat chronic sinusitis, inflammation of the nasal sinuses, by inserting a tiny balloon to enlarge the sinus cavity openings.
The company just raised its quarterly dividend to $0.63 in January 2026, a 6.8% increase from the prior $0.59 rate. That puts the annual payout at $2.52 per share with a yield around 1.9%. Not eye-popping, but the safety and growth profile more than compensate. Abbott generated $6.35 billion in free cash flow in 2024 against $3.84 billion in dividend payments.
Every year, more than two million implants are placed worldwide. While these devices are life-saving, complications often arise from scarring and infection around the implant. To counter this, Hylomorph created Hylomate, a biocompatible pouch that wraps the implant to safeguard the body. However, its soft and slippery surface made it difficult to handle with conventional surgical tools. Standard tweezers could tear the pouch, while direct hand contact risked contamination, calling for a new solution.
The nebulizer is transformed into an animal-shaped inhalation device, blending therapeutic function with playful engagement and turning fear into connection for children.
The Spinamic brace is a next-generation spinal orthosis designed specifically for the treatment and management of scoliosis, a condition where the spine curves sideways.